DLD Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

DLD Asset Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-150,000	Closed	-$5.07M	–	187
2021 Q2	$5.07M	Buy	+150,000	New	+$3.82M	0.35%	59

DLD Asset Management's CNST Position: Q3 2021 in Review

DLD Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 150,000 shares — an estimated $5.07M sold.

DLD Asset Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $5.07M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

DLD Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
DLD Asset Management sold 150,000 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $5.07M.
DLD Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
DLD Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $5.07M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on DLD Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.